APLT
Price:
$0.2299
Market Cap:
$33.09M
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products in...[Read more]
Industry
Biotechnology
IPO Date
2019-05-14
Stock Exchange
NASDAQ
Ticker
APLT
According to Applied Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 23.64M. This represents a change of -41.45% compared to the average of 40.38M of the last 4 quarters.
The mean historical Enterprise Value of Applied Therapeutics, Inc. over the last ten years is 172.46M. The current 23.64M Enterprise Value has changed 1.27% with respect to the historical average. Over the past ten years (40 quarters), APLT's Enterprise Value was at its highest in in the September 2024 quarter at 1.13B. The Enterprise Value was at its lowest in in the June 2022 quarter at -29103471.80.
Average
172.46M
Median
130.10M
Minimum
14.07M
Maximum
428.82M
Discovering the peaks and valleys of Applied Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.56%
Maximum Annual Enterprise Value = 428.82M
Minimum Annual Increase = -92.07%
Minimum Annual Enterprise Value = 14.07M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 42.87M | -81.61% |
| 2023 | 233.10M | 1.56% |
| 2022 | 14.07M | -92.07% |
| 2021 | 177.34M | -58.65% |
| 2020 | 428.82M | 28.69% |
| 2019 | 333.22M | 394.51% |
| 2018 | 67.38M | -18.67% |
The current Enterprise Value of Applied Therapeutics, Inc. (APLT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
96.68M
5-year avg
179.24M
10-year avg
172.46M
Applied Therapeutics, Inc.’s Enterprise Value is less than Molecular Partners AG (45.15M), less than Elicio Therapeutics, Inc. (128.40M), less than Corbus Pharmaceuticals Holdings, Inc. (116.42M), less than Cardiff Oncology, Inc. (136.29M), less than PepGen Inc. (347.79M), less than Milestone Pharmaceuticals Inc. (235.37M), less than Rani Therapeutics Holdings, Inc. (123.77M), less than Nkarta, Inc. (155.82M), less than Cassava Sciences, Inc. (48.00M), less than Forte Biosciences, Inc. (164.14M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 45.15M | $168.84M | |
| 128.40M | $143.68M | |
| 116.42M | $134.00M | |
| 136.29M | $145.42M | |
| 347.79M | $365.00M | |
| 235.37M | $224.85M | |
| 123.77M | $114.60M | |
| 155.82M | $130.69M | |
| 48.00M | $160.38M | |
| 164.14M | $257.55M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Applied Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Applied Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Applied Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Applied Therapeutics, Inc. (APLT)?
What is the 3-year average Enterprise Value for Applied Therapeutics, Inc. (APLT)?
What is the 5-year average Enterprise Value for Applied Therapeutics, Inc. (APLT)?
How does the current Enterprise Value for Applied Therapeutics, Inc. (APLT) compare to its historical average?